$VEEV

Schwenger Thomas D. sold $9.0M of VEEV

Schwenger Thomas D. (Pres. & Chief Customer Officer) sold 36,000 shares of VEEVA SYSTEMS INC (VEEV) at an average of $250.23 ($241.91–$251.03, $9.01M total) across 3 trades on 2026-08-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schwenger Thomas D.
Published Aug 17, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 8:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VEEV
Neutral
medium confidence
Mentioned
$VEEV
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VEEVNeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size (about $9.0M) and the fact it occurred on Aug 13 across multiple trades at prices roughly $241.91 to $251.03 per share.

02

Market read

Traders may briefly reassess sentiment around insider behavior, but the 10b5-1 designation makes it less likely to drive a sustained repricing.

03

What to watch

The filing does not disclose reasons for the sale, and it is only one executive’s activity, not a broad insider trend across the company.

Relevance 5/10Novelty 4/10Timing: filed Aug 17, covering sales dated Aug 13

Background

This is an SEC Form 4 insider transaction for Veeva Systems, filed Aug 17, detailing open-market sales by Thomas D. Schwenger (Pres. and Chief Customer Officer).

Company-level read

Ticker impact

$VEEVNeutralMedium confidence
Context

Veeva Systems insider Thomas D. Schwenger sold about $9.0M of VEEV shares via an open-market sale under a 10b5-1 plan.

Expected impact

Near-term impact likely limited; any reaction would be sentiment-driven rather than a new fundamental catalyst.

Evidence & confidence

Form 4 provides a fresh, company-specific datapoint (sale size, date, and role). However, 10b5-1 pre-arrangement typically dampens interpretability versus discretionary selling.

Market effects

Minimal; this is an issuer-specific insider transaction with no stated sector-wide regulatory or competitive change.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Veeva Systems Inc

    Subject of the Form 4 insider sale disclosure.

  • Thomas D. Schwenger

    Pres. and Chief Customer Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VEEVMed

CFRA upgrades Veeva Systems (VEEV) to a Buy

CFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.

$VEEVHighAI 8/10

Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.

Veeva Systems reported a 37% increase in net income to $273.4M and raised fiscal 2027 revenue guidance to $3.682B-$3.687B. Michael Burry trimmed his position but remains bullish, citing the company's intrinsic value and growth potential. Analysts expect Q3 EPS of $1.68 and have raised price targets, with a consensus 'Moderate Buy' rating and $292.52 average target.

$VEEVMedAI 8/10

Veeva Rises on Sales and Margin Gains, Guidance Raise

Veeva Systems (VEEV) reported Q2 fiscal 2027 revenue of $928M, up 18% YoY, with non-GAAP operating income of $415.9M. The company raised guidance to $3.687B in revenue and $9.21 in non-GAAP EPS. VEEV shares have risen 25% YTD, supported by strong institutional demand and robust fundamentals, including 3-year sales and EPS growth rates of 14.1% and 21.6%, respectively.

$VEEVHighAI 8/10

Watch Veeva, CrowdStrike, and More

Veeva Systems (VEEV) reported Q2 non-GAAP EPS of $2.35, revenue growth of 17.6% Y/Y to $928M, and raised its Q3 revenue forecast. CrowdStrike (CRWD) posted 25.6% Y/Y revenue growth to $1.47B. Dycom Industries (DY) fell 11.6% despite 45.6% Y/Y revenue growth to $2.01B due to segment pressures and higher costs.

$VEEVHighAI 8/10

Veeva (VEEV) Q2 2027 Earnings Call Transcript

Veeva Systems (VEEV) reported Q2 2027 revenues of $928.0 million, up 18% YoY, driven by growth in commercial and R&D segments. Subscription revenues rose 16% to $766.8 million. Non-GAAP operating income was $415.9 million, with a 44.8% margin. The company raised FY 2027 revenue guidance to $3.682B-$3.687B and EPS guidance to $9.21. Management highlighted strong adoption of Vault CRM and Data Cloud solutions, with 12 top 20 biopharmas committed to Vault CRM. Risks include the launch of the new Fa